… agreement with Metsera," Pfizer said. We believe that … about, among other topics, Pfizer's proposed acquisition … Metsera, lawsuits filed by Pfizer against Metsera, its controlling … maintain, defend and enforce patent or other intellectual property …

… . According to Reuters, Pfizer recently raised its offer … hearing is scheduled. For Pfizer, acquiring Metsera represents a … additional milestone payments, while Pfizer's bid, including … treatments, particularly as key patents like semaglutide, the active …

… Executive Daily, we cover Pfizer’s lawsuits against Metsera … licensing agreements driving innovation. Pfizer has filed lawsuits against … both companies infringed on patents related to GLP-1 … drug platforms overlap with Pfizer’s proprietary research, highlighting …

… selling medicines facing looming patent expirations. Speaking to … s September agreement with Pfizer. Metsera shares extended gains … under the Pfizer merger agreement. UPBEAT RESULTS Pfizer earlier … reduced the eligible population. Pfizer last month became the …

… September 2025. Announced Pfizer entered into a definitive … in the business, Pfizer believes presenting operational variances … loss of patent coverage; (ii) claims of patent infringement, … this earnings release. All trademarks mentioned are the property …

… reimbursement policy that impacted off-patent brands in Japan. We also … shift of commercial rights from Pfizer back to us. And secondly …

… just announced that AstraZeneca and Pfizer will start charging foreign health … undoubtedly threaten to break their patents and issue compulsory licenses to …

… .” Patrizia Cavazzoni, a psychiatrist, left Pfizer in 2018 to eventually become … ’s inauguration. Five weeks later, Pfizer announced she would return as … Pharma. Under his leadership, Horizon patented the arthritis painkiller Duexis, a …

… BioNTech, the originator of the Pfizer jab) and the wider financial … significant factor is a forthcoming “patent cliff edge” — the biggest … revenue from products where the patents are due to expire in … drugs that will come off patent between now and 2033. Once …

… battle with U.S. rival Pfizer for biotech Metsera. Doustdar said … would win the bidding with Pfizer for Metsera. Novo has bid … U.S. insurance budgets, and patent expiries. "If you add …